NYSE:VAR - Varian Medical Systems Stock Price, Price Target & More

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

Varian Medical Systems, Inc. (NYSE:VAR) announced its earnings results on Wednesday, April, 25th. The medical equipment provider reported $1.15 EPS for the quarter, topping the Zacks' consensus estimate of $1.04 by $0.11. The medical equipment provider earned $729.90 million during the quarter, compared to the consensus estimate of $685.86 million. Varian Medical Systems had a net margin of 4.77% and a return on equity of 27.99%. The firm's revenue was up 10.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.89 earnings per share. View Varian Medical Systems' Earnings History.

Varian Medical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Varian Medical Systems.

Varian Medical Systems updated its FY18 earnings guidance on Wednesday, April, 25th. The company provided EPS guidance of $4.43-4.53 for the period, compared to the Thomson Reuters consensus estimate of $4.40. The company issued revenue guidance of +6-9% (Approx $3.11-3.21 billion), compared to the consensus revenue estimate of $2.79 billion.

8 equities research analysts have issued twelve-month price objectives for Varian Medical Systems' stock. Their forecasts range from $98.00 to $132.00. On average, they anticipate Varian Medical Systems' share price to reach $111.2857 in the next twelve months. This suggests that the stock has a possible downside of 4.3%. View Analyst Ratings for Varian Medical Systems.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 3 sell ratings, 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Varian Medical Systems include SONOVA Hldg AG/ADR (SONVY), Masimo (MASI), LivaNova (LIVN), GETINGE AB/ADR (GNGBY), CONMED (CNMD), NxStage Medical (NXTM), AxoGen, Inc Common Stock (AXGN), Natus Medical (BABY), Viewray (VRAY), Cutera (CUTR), BioLife Solutions (BLFS), Vision Sciences (CGNT), Rockwell Medical (RMTI), Fonar (FONR) and Helius Medical Technologies (HSDT).

Media coverage about VAR stock has trended somewhat positive this week, Accern Sentiment reports. The research firm scores the sentiment of media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Varian Medical Systems earned a coverage optimism score of 0.10 on Accern's scale. They also gave news stories about the medical equipment provider an impact score of 44.94 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Varian Medical Systems' stock is owned by many different of institutional and retail investors. Top institutional investors include Alecta Pensionsforsakring Omsesidigt (1.74%), Bank of Montreal Can (0.11%), Montrusco Bolton Investments Inc. (0.10%), JLB & Associates Inc. (0.09%), DnB Asset Management AS (0.06%) and State of Alaska Department of Revenue (0.04%). Company insiders that own Varian Medical Systems stock include Clarence R Verhoef, David J Illingworth, Dow R Wilson, Elisha W Finney, John W Kuo, Kolleen T Kennedy, Magnus Momsen, Mark R Laret, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.

VAR stock was sold by a variety of institutional investors in the last quarter, including Alecta Pensionsforsakring Omsesidigt, State of Alaska Department of Revenue, Meag Munich Ergo Kapitalanlagegesellschaft MBH and TNB Financial. Company insiders that have sold Varian Medical Systems company stock in the last year include David J Illingworth, Dow R Wilson, John W Kuo, Kolleen T Kennedy, Magnus Momsen, Mark R Laret, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.

VAR stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can, DnB Asset Management AS, Montrusco Bolton Investments Inc., Clinton Group Inc., Cohen Klingenstein LLC, Welch & Forbes LLC, Bright Rock Capital Management LLC and Gateway Investment Advisers LLC. View Insider Buying and Selling for Varian Medical Systems.

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of VAR stock can currently be purchased for approximately $116.25.

Varian Medical Systems has a market capitalization of $10.65 billion and generates $2.67 billion in revenue each year. The medical equipment provider earns $249.60 million in net income (profit) each year or $3.60 on an earnings per share basis. Varian Medical Systems employs 6,600 workers across the globe.

Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]